The company recorded a 36 million yen special loss from early redemption of convertible bonds issued in April 2021, and an additional 25 million yen loan loss provision for loans to subsidiary Axel Medica Co., Ltd. The loan loss provision is eliminated in consolidated accounting and does not impact consolidated earnings.
¥61M
›
Summary
The company recorded a 36 million yen special loss from early redemption of convertible bonds issued in April 2021, and an additional 25 million yen loan loss provision for loans to subsidiary Axel Medica Co., Ltd. The loan loss provision is eliminated in consolidated accounting and does not impact consolidated earnings.